MSB 2.51% 97.0¢ mesoblast limited

Editorial from Biotech Daily, page-55

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    And 2 of them are funding the cost,not bad for a Biotech in advanced trials!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.